Open access · CC-BY
via OpenAlex
Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
Javier Donate‐Correa, Carla María Ferri, Ernesto Martín‐Núñez, Nayra Pérez‐Delgado, Ainhoa González-Luis, Carmen Mora Fernández, Juan F. Navarro‐González
Scientific Reports · 2021 · ▲ 34 citations
Abstract
Abstract Chronic kidney disease (CKD) has been associated with a higher risk of cardiovascular disease (CVD). CKD patients present a decrease in the levels of the protein Klotho that accompanies the decrease in kidney function. This protein has been related to protective effects against CVD. However, it is unclear whether circulating Klotho, and its expression in peripheral blood cells (PBCs) are also associated with subclinical atherosclerosis in CKD. The present study aimed to study the relationship between Klotho and subclinical atherosclerosis in a population of patients with moderate to severe CKD. We determined the serum levels and gene expression in PBCs levels of Klotho and three inflammatory cytokines in 103 patients with CKD and investigated their relationship with two surrogate markers of subclinical atherosclerotis: ankle-brachial index (ABI) and carotid intima-media thickness (CIMT). Patients with subclinical atherosclerosis presented lower serum and PBCs expression levels of Klotho. Both variables were associated with the presence of subclinical atherosclerosis, being directly related with ABI and inversely with CIMT (P < 0.0001 for both). Multiple regression analysis demonstrated that both variables were significant determinants for ABI (adjusted R2 = 0.511, P < 0.0001) and CIMT (adjusted R2 = 0.445, P < 0.0001), independently of traditional and emergent cardiovascular risk factors. Moreover, both constituted protective factors against subclinical atherosclerosis [OR: 0.993 (P = 0.002) and 0.231 (P = 0.025), respectively]. Receiver operating characteristic analysis pointed to the utility of serum Klotho (area under the curve [AUC]: 0.817, 95% CI: 0.736–0.898, P < 0.001) and its gene expression in PBCs (AUC: 0.742, 95% CI: 0.647–0.836, P < 0.001) to distinguish subclinical atherosclerosis. The reductions in serum and PBCs expression levels of Klotho in CKD patients are independently associated with the presence of for subclinical atherosclerosis. Further research exploring whether therapeutic approaches to maintain or elevate Klotho could reduce the impact of CVD in CKD patients is warranted.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-021-95488-4
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Donate‐Correa, J., Ferri, C.M., Martín‐Núñez, E., Pérez‐Delgado, N., González-Luis, A., Fernández, C.M., & Navarro‐González, J.F. (2021). Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-021-95488-4
Vancouver
Donate‐Correa J, Ferri CM, Martín‐Núñez E, Pérez‐Delgado N, González-Luis A, Fernández CM, et al. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease. Scientific Reports. 2021. doi:10.1038/s41598-021-95488-4.
BibTeX
@article{javier2021Klotho,
title = {Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease},
author = {Javier Donate‐Correa and Carla María Ferri and Ernesto Martín‐Núñez and Nayra Pérez‐Delgado and Ainhoa González-Luis and Carmen Mora Fernández and Juan F. Navarro‐González},
journal = {Scientific Reports},
year = {2021},
doi = {10.1038/s41598-021-95488-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2013
Open access · CC-BY
A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
Tianjin Yike Daxue xuebao 2004
Citation only
Expression of hTERT mRNA and correlation with telomerase activity and their clinical significance in colorectal cancer
BMC Nephrology 2018
Open access · CC-BY
The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study
2016
Citation only
Research progress of the relationship between klotho protein and chronic kidney disease
International Journal of Molecular Sciences 2023
Open access · CC-BY
Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
Nephrology Dialysis Transplantation 2016
Open access · OA